文献速递头颈外科

高风险头颈部皮肤鳞状细胞癌的前哨淋巴结活检

Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma of the head and neck.
PubMed 文献 · Laryngoscope · 2019-03-07

该回顾性病例系列描述了单中心对高风险头颈部皮肤鳞状细胞癌患者行前哨淋巴结活检(SLNB)的结局。83例成功行SLNB,5例(6%)前哨淋巴结阳性,阴性预测值为95%至100%。就诊时局部复发肿瘤、起源于慢性炎症区域及免疫抑制与后续复发风险增加显著相关,平均随访19.9个月。

要点

  • SLNB可用于识别头颈部皮肤鳞状细胞癌的区域淋巴结转移,阴性预测值为95%至100%。
  • 83例成功行SLNB的患者中,5例(6%)前哨淋巴结阳性。
  • 就诊时局部复发肿瘤、起源于慢性炎症区域及免疫抑制与后续复发风险增加显著相关。

核心结论

  • SLNB可用于识别头颈部皮肤鳞状细胞癌的区域淋巴结转移,阴性预测值为95%至100%。
  • 与复发相关的因素为就诊时局部复发肿瘤、起源于慢性炎症区域及免疫抑制。

研究设计与样本

  • 回顾性病例系列,对2007年12月至2018年5月间就诊的临床淋巴结阴性头颈部皮肤鳞状细胞癌患者进行病历回顾。
  • 符合高风险标准的患者接受SLNB及切除,伴或不伴辅助治疗;既往行颈淋巴结清扫的患者被排除。

主要发现

  • 83例患者成功行SLNB,1例因术中发现的隐匿性淋巴结转移行选择性颈淋巴结清扫。
  • 5例患者(6%)前哨淋巴结阳性,其中4/5接受进一步治疗(颈淋巴结清扫、放疗和/或全身治疗),末次随访时无进一步复发。
  • SLNB的阴性预测值为95%至100%。
  • 就诊时局部复发肿瘤、起源于慢性炎症区域及免疫抑制与后续复发风险增加显著相关,平均随访19.9个月。

关键数值与推荐

  • SLNB阴性预测值为95%至100%。
  • 前哨淋巴结阳性率为5/83(6%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: To describe outcomes of a single institution experience with sentinel lymph node biopsy (SLNB) for high-risk cutaneous squamous cell carcinoma of the head and neck. STUDY DESIGN: Retrospective case series. METHODS: Chart review was performed for patients who presented with clinically node negative cutaneous squamous cell carcinoma of the head and neck between December 2007 and May 2018. Patients who met high-risk criteria underwent SLNB and excision, with or without adjuvant therapy. Patients who underwent prior neck dissection were excluded. The main outcomes were SLNB result, lymph node spread, recurrence-free survival, disease-specific survival, and overall survival. RESULTS: Eighty-three patients underwent successful SLNB, and one patient underwent selective neck dissection for intraoperatively identified occult lymph node metastasis. Five patients (6%) had a sentinel node positive for tumor, of whom 4/5 received further treatment (neck dissection, radiation, and/or systemic therapy) with no further recurrence at the time of last follow-up. SLNB had a negative predictive value of 95% to 100%. Recurrent tumor at presentation, tumor arising from an area of chronic inflammation, and immunosuppression were significantly associated with increased risk of subsequent recurrence, with a mean follow-up of 19.9 months. CONCLUSIONS: SLNB can be used to identify regional lymph node metastases in cutaneous squamous cell carcinoma of the head and neck with a high negative predictive value (95%-100%). Factors associated with recurrence were tumor being locally recurrent at presentation, arising from an area of chronic inflammation, and immunosuppression. LEVEL OF EVIDENCE: 4 Laryngoscope, 130:108-114, 2020.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Wu MP, Sethi RKV, Emerick KS, et al. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma of the head and neck. Laryngoscope. 2019. PMID: 30843617. doi:10.1002/lary.27881

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。